Rich Vincent | Chief Financial Officer |
James Breitmeyer | President & Chief Executive Officer |
Salim Yazji | Chief Medical Officer |
Hartaj Singh | Oppenheimer and Company |
Carl Byrnes | Northland Capital Markets |
Shubhendu Sen Roy | Brookline Capital Management |
Greetings. Welcome to the Oncternal Therapeutics, Inc. Q3 2021 Financial Results Call. At this time, all participants are in listen only mode. A question-and-answer session will follow the formal presentation.